Endovascular management of cerebral vasospasm

Neurosurgery

Volumn 59, Issue 5 SUPPL., 2006, Pages

  Zwienenberg Lee, Marike ^a,b   Hartman, Jonathan ^b   Rudisill, Nancy ^a   Muizelaar, Jan Paul ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cerebral vasospasm; Endovascular therapy; Papaverine; Transluminal balloon angioplasty

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; NICARDIPINE; NIMODIPINE; PAPAVERINE; VERAPAMIL;

ANEURYSM RUPTURE; BRAIN INFARCTION; BRAIN VASOSPASM; CLINICAL TRIAL; DISEASE EXACERBATION; ENDOVASCULAR SURGERY; HEART DISEASE; HEMATOMA; HEMIPARESIS; HUMAN; HYPOTENSION; INTRACRANIAL HYPERTENSION; MYDRIASIS; NONHUMAN; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; RESPIRATORY ARREST; REVIEW; SEIZURE;

EID: 33750360332     PISSN: 0148396X     EISSN: None     Source Type: Journal    
DOI: 10.1227/01.NEU.0000239252.07760.59     Document Type: Review

References (86)

1. Allen GS, Ahn HS, Preziosi TJ, Battye R, Boone SC, Chou SN, Kelly DL Jr, Weir BK, Crabbe RA, Lavik PJ, Rosenbloom SB, Dorsey FC, Ingram CR, Mellits DE, Bertsch LA, Boisvert DP, Hundley MB, Johnson RK, Strom JA, Transou CR: Cerebral arterial spasm - A controlled trial of nimodipine in patients with subarachnoid hemorrhage. N Engl J Med 308:619-624, 1983.
2. Andaluz N, Tomsick TA, Tew JM Jr, van Loveren HR, Yeh HS, Zuccarello M: Indications for endovascular therapy for refractory vasospasm after aneurysmal subarachnoid hemorrhage: Experience at the University of Cincinnati. Surg Neurol 58:131-138,, 2002.
3. Badjatia N, Mehmet A, Topcuoglu J: Preliminary experience with intraarterial Nicardipine as a treatment for cerebral vasospasm. AJNR Am J Neuroradiol 25:819-826, 2004.
4. Barnwell SL, Higashida RT, Halbach VV, Dowd CF, Wilson CB, Hieshima GB: Transluminal angioplasty of intracerebral vessels for cerebral arterial spasm: Reversal of neurological deficits after delayed treatment. Neurosurgery 25:424-429, 1989.
5. Barr JD, Mathis JM, Horton JA: Transient severe brain stem depression during intraarterial Papaverine infusion for cerebral vasospasm. AJNR Am J Neuroradiol 15:719-723, 1994.
6. Barreau X, Pastore M, Piotin C: Endovascular treatment of cerebral vasospasm following SAH. Acta Neurochir (Wien) 77:177-180, 2001.
7. Bejjani GK, Bank WO, Olan WJ, Sekhar LN: The efficacy and safety of angioplasty for cerebral vasospasm after subarachnoid hemorrhage. Neurosurgery 42:979-986, 1998.
8. Biondi A, Ricciardi G, Puybasset L: Intra-arterial Nimodipine for the treatment of symptomatic cerebral vasospasm after aneurysmal subarachnoid hemorrhage. AJNR Am J Neuroradiol 25:1067-1076, 2004.
9. Bolton TB: Mechanisms of action of transmitters and other substances on smooth muscle. Physiol Rev 59:606-718, 1979.
10. Carhuapoma JR, Qureshi AI, Tamargo RJ, Mathis JM, Hanley DF: Intraarterial Papaverine-induced seizures: Case report and review of the literature. Surg Neurol 56:159-163, 2001.
11. Chia RY, Hughes RS, Morgan MK: Magnesium: A useful adjunct in the prevention of cerebral vasospasm following aneurysmal subarachnoid haemorrhage. J Clin Neurosci 9:279-281, 2002.
12. Clouston JE, Numaguchi Y, Zoarski GH, Aldrich EF, Simard JM, Zitnay KM: Intraarterial Papaverine infusion for cerebral vasospasm after subarachnoid hemorrhage. AJNR Am J Neuroradiol 16:27-38, 1995.
13. Clyde BL, Firlik AD, Kaufmann AM, Spearman MP, Yonas H: Paradoxical aggravation of vasospasm with Papaverine infusion following aneurysmal subarachnoid hemorrhage. Case report. J Neurosurg 84:690-695, 1996.
14. Cook P, James I: Cerebral vasodilators (second of two parts). N Engl J Med 305:1560-1564, 1981.
15. Cook P, James I: Drug therapy: Cerebral vasodilators (first of two parts). N Engl J Med 305:1508-1513, 1981.
16. Critchley M: The anterior cerebral artery and its syndromes. Brain 53:120-165, 1930.
17. Dehdashti AR, Mermillod B, Rufenacht DA, Reverdin A, de Tribolet N: Does treatment modality of intracranial ruptured aneurysms influence the incidence of cerebral vasospasm and clinical outcome? Cerebrovasc Dis 17:53-60, 2004.
18. Dorsch N: Incidence, effects and treatment of ischemia following aneurysm rupture, in Sano KT, Kassell NF, Saaki T (eds): Cerebral Vasospasm. Tokyo, University of Tokyo Press, 1990, pp 495-498.
19. Eskridge JM, McAuliffe W, Song JK, Deliganis AV, Newell DW, Lewis DH, Mayberg MR, Winn HR: Balloon angioplasty for the treatment of vasospasm: Results of first 50 cases. Neurosurgery 42:510-517, 1998.
20. Eskridge JM, Newell DW, Pendleton GA: Transluminal angioplasty for treatment of vasospasm. Neurosurg Clin N Am 1:387-399, 1990.
21. Eskridge JM, Newell DW, Winn HR: Endovascular treatment of vasospasm. Neurosurg Clin N Am 5:437-447, 1994.
22. Eskridge JM, Song JK: A practical approach to the treatment of vasospasm. AJNR Am J Neuroradiol 18:1653-1660, 1997.
23. Eskridge JM, Song JK, Elliott JP, Newell DW, Grady MS, Winn HR: Balloon angioplasty of the A1 segment of the anterior cerebral artery narrowed by vasospasm. Technical note. J Neurosurg 91:153-156, 1999.
24. Fandino J, Kaku Y, Schuknecht B, Valavanis A, Yonekawa Y: Improvement of cerebral oxygenation patterns and metabolic validation of superselective intraarterial infusion of Papaverine for the treatment of cerebral vasospasm. J Neurosurg 89:93-100, 1998.
25. Feng L, Fitzsimmons B, Young W: Intra-arterially administered verampil as adjunct therapy for cerebral vasospasm: Safety and 2-year experience. AJNR Am J Neuroradiol 23:1284-1290, 2002.
26. Findlay JM, Kassell NF, Weir BK, Haley EC Jr, Kongable G, Germanson T, Truskowski L, Alves WM, Holness RO, Knuckey NW: A randomized trial of intraoperative, intracisternal tissue plasminogen activator for the prevention of vasospasm. Neurosurgery 37:168-177, 1995.
27. Firlik KS, Kaufmann AM, Firlik AD, Jungreis CA, Yonas H: Intra-arterial Papaverine for the treatment of cerebral vasospasm following aneurysmal subarachnoid hemorrhage. Surg Neurol 51:66-74, 1999.
28. Fisher CM: Clinical syndromes in cerebral thrombosis, hypertensive hemorrhage, and ruptured saccular aneurysm. Clin Neurosurg 22:117-147, 1975.
29. Fisher CM, Kistler JP, Davis JM: Relation of cerebral vasospasm to subarachnoid hemorrhage visualized by computerized tomographic scanning. Neurosurgery 6:1-9, 1980.
30. Fisher CM, Roberson GH, Ojemann RG: Cerebral vasospasm with ruptured saccular aneurysm - The clinical manifestations. Neurosurgery 1:245-248, 1977.
31. Fujii Y, Takahashi A, Yoshimoto T: Effect of balloon angioplasty on high grade symptomatic vasospasm after subarachnoid hemorrhage. Neurosurg Rev 18:7-13, 1995.
32. Graves VB: Advancing loop technique for endovascular access to the anterior cerebral artery. AJNR Am J Neuroradiol 19:778-780, 1998.
33. Grotenhuis JA, Bettag W, Fiebach BJ, Dabir K: Intracarotid slow bolus injection of nimodipine during angiography for treatment of cerebral vasospasm after SAH. A preliminary report. J Neurosurg 61:231-240, 1984.
34. Haley EC Jr, Kassell NF, Torner JC: A randomized controlled trial of high-dose intravenous nicardipine in aneurysmal subarachnoid hemorrhage. A report of the Cooperative Aneurysm Study. J Neurosurg 78:537-547, 1993.
35. Haley EC Jr, Kassell NF, Torner JC, Truskowski LL, Germanson TP: A randomized trial of two doses of nicardipine in aneurysmal subarachnoid hemorrhage. A report of the Cooperative Aneurysm Study. J Neurosurg 80:788-796, 1994.
36. Hamada J, Kai Y, Morioka M, Yano S, Mizuno T, Hirano T, Kazekawa K, Ushio Y: Effect on cerebral vasospasm of coil embolization followed by microcatheter intrathecal urokinase infusion into the cisterna magna: A prospective randomized study. Stroke 34:2549-2554, 2003.
37. Higashida RT, Halbach VV, Cahan LD, Brant-Zawadzki M, Barnwell S, Dowd C, Hieshima GB: Transluminal angioplasty for treatment of intracranial arterial vasospasm. J Neurosurg 71:648-653, 1989.
38. Higashida RT, Halbach VV, Dormandy B, Bell J, Brant-Zawadzki M, Hieshima GB: New microballoon device for transluminal angioplasty of intracranial arterial vasospasm. AJNR Am J Neuroradiol 11:233-238, 1990.
39. Higashida RT, Halbach VV, Dowd CF, Dormandy B, Bell J, Hieshima GB: Intravascular balloon dilatation therapy for intracranial arterial vasospasm: Patient selection, technique, and clinical results. Neurosurg Rev 15:89-95, 1992.
40. Honma Y, Fujiwara T, Irie K, Ohkawa M, Nagao S: Morphological changes in human cerebral arteries after percutaneous transluminal angioplasty for vasospasm caused by subarachnoid hemorrhage. Neurosurgery 36:1073-1080, 1995.
41. Kaku Y, Yonekawa Y, Tsukahara T, Kazekawa K: Superselective intraarterial infusion of Papaverine for the treatment of cerebral vasospasm after subarachnoid hemorrhage. J Neurosurg 77:842-847, 1992.
42. Kassell NF, Helm G, Simmons N, Phillips CD, Cail WS: Treatment of cerebral vasospasm with intra-arterial Papaverine. J Neurosurg 77:848-852, 1992.
43. Kassell NF, Torner JC, Haley EC Jr, Jane JA, Adams HP, Kongable GL: The International Cooperative Study on the Timing of Aneurysm Surgery. Part 1: Overall management results. J Neurosurg 73:18-36, 1990.
44. Kassell NF, Torner JC, Jane JA, Haley EC Jr, Adams HP: The International Cooperative Study on the Timing of Aneurysm Surgery. Part 2: Surgical results. J Neurosurg 73:37-47, 1990.
45. Katoh H, Shima K, Shimizu A, Takiguchi H, Miyazawa T, Umezawa H, Nawashiro H, Ishihara S, Kaji T, Makita K, Tsuchiya K: Clinical evaluation of the effect of percutaneous transluminal angioplasty and intra-arterial Papaverine infusion for the treatment of vasospasm following aneurysmal suarchnoid hemorrhage. Neurol Res 21:195-203, 1999.
46. Le Roux PD, Newell DW, Eskridge J, Mayberg MR, Winn HR: Severe symptomatic vasospasm: The role of immediate postoperative angioplasty. J Neurosurg 80:224-229, 1994.
47. Linskey ME, Horton JA, Rao GR, Yonas H: Fatal rupture of the intracranial carotid artery during transluminal angioplasty for vasospasm induced by subarachnoid hemorrhage. Case report. J Neurosurg 74:985-990, 1991.
48. Liu JK, Tenner MS, Gottfried ON, Stevens EA, Rosenow JM, Madan N, MacDonald JD, Kestle JR, Couldwell WT: Efficacy of multiple intraarterial Papaverine infusions for improvement in cerebral circulation time in patients with recurrent cerebral vasospasm. J Neurosurg 100:414-421, 2004.
49. Livingston K, Guterman LR, Hopkins LN: Intraarterial Papaverine as an adjunct to transluminal angioplasty for vasospasm induced by subarachnoid hemorrhage. AJNR Am J Neuroradiol 14:346-347, 1993.
50. MacDonald RL, Wallace MC, Montanera WJ, Glen JA: Pathological effects of angioplasty on vasospastic carotid arteries in a rabbit model. J Neurosurg 83:111-117, 1995.
51. Macdonald RL, Zhang J, Han H: Angioplasty reduces pharmacologically mediated vasoconstriction in rabbit carotid arteries with and without vasospasm. Stroke 26:1053-1060, 1995.
52. Marks MP, Steinberg GK, Lane B: Intraarterial Papaverine for the treatment of vasospasm. AJNR Am J Neuroradiol 14:822-826, 1993.
53. Mathis JM, DeNardo A, Jensen ME, Scott J, Dion JE: Transient neurologic events associated with intraarterial Papaverine infusion for subarachnoid hemorrhage-induced vasospasm. AJNR Am J Neuroradiol 15:1671-1674, 1994.
54. Mathis JM, Jensen ME, Dion JE: Technical considerations on intra-arterial Papaverine hydrochloride for cerebral vasospasm. Neuroradiology 39:90-98, 1997.
55. Matsui T, Kaizu H, Itoh S, Asano T: The role of active smooth-muscle contraction in the occurrence of chronic vasospasm in the canine two-hemorrhage model. J Neurosurg 80:276-282, 1994.
56. Megyesi JF, Findlay JM, Vollrath B, Cook DA, Chen MH: In vivo angioplasty prevents the development of vasospasm in canine carotid arteries. Pharmacological and morphological analyses. Stroke 28:1216-1224, 1997.
57. Miyamoto M, Takayanagi I, Okhubo H: Actions of Papaverine on intestinal smooth muscle and its inhibition of cyclic AMP and cyclic GMP phosphodiesterases. Jpn J Pharmacol 26:114-117, 1976.
58. Morgan MK, Jonker B, Finfer S, Harrington T, Dorsch NW: Aggressive management of aneurysmal subarachnoid haemorrhage based on a Papaverine angioplasty protocol. J Clin Neurosci 7:305-308, 2000.
59. Muizelaar JP, Madden LK: Balloon prophylaxis of aneurysmal vasospasm. Acta Neurochir Suppl 77:185-190, 2001.
60. Muizelaar JP, Zwienenberg M, Rudisill NA, Hecht ST: The prophylactic use of transluminal balloon angioplasty in patients with Fisher Grade 3 subarachnoid hemorrhage: A pilot study. J Neurosurg 91:51-58, 1999.
61. Murayama Y, Song JK, Uda K, Gobin YP, Duckwiler GR, Tateshima S, Patel AB, Martin NA, Viñuela F: Combined endovascular treatment for both intracranial aneurysm and symptomatic vasospasm. AJNR Am J Neuroradiol 24:133-139, 2003.
62. Newell DW, Elliott JP, Eskridge JM, Winn HR: Endovascular therapy for aneurysmal vasospasm. Crit Care Clin 15:685-699, 1999.
63. Newell DW, Eskridge JM, Aaslid R: Current indications and results of cerebral angioplasty. Acta Neurochir Suppl 77:181-183, 2001.
64. Newell DW, Eskridge JM, Mayberg MR, Grady MS, Winn HR: Angioplasty for the treatment of symptomatic vasospasm following subarachnoid hemorrhage. J Neurosurg 71:654-660, 1989.
65. Ohman J, Heiskanen O: Effect of nimodipine on the outcome of patients after aneurysmal subarachnoid hemorrhage and surgery. J Neurosurg 69:683-686, 1988.
66. Oskouian RJ Jr, Martin NA, Lee JH, Glenn TC, Guthrie D, Gonzalez NR, Afari A, Viñuela F: Multimodal quantitation of the effects of endovascular therapy for vasospasm on cerebral blood flow, transcranial Doppler ultrasonographic velocities, and cerebral artery diameters. Neurosurgery 51:30-41, 2002.
67. Pickard JD, Murray GD, Illingworth R, Shaw MD, Teasdale GM, Foy PM, Humphrey PR, Lang DA, Nelson R, Richards P, et al: Effect of oral nimodipine on cerebral infarction and outcome after subarachnoid haemorrhage: British aneurysm nimodipine trial. BMJ 298:636-642, 1989.
68. Poch G, Kukovetz W: Papaverine-induced inhibition of phosphodiesterase activity in various mammalian tissues. Life Sci 10:133-144, 1971.
69. Polin RS, Coenen VA, Hansen CA, Shin P, Baskaya MK, Nanda A, Kassell NF: Efficacy of transluminal angioplasty for the management of symptomatic cerebral vasospasm following aneurysmal subarachnoid hemorrhage. J Neurosurg 92:284-290, 2000.
70. Polin RS, Hansen CA, German P, Chadduck JB, Kassell NF: Intra-arterially administered Papaverine for the treatment of symptomatic cerebral vasospasm. Neurosurgery 42:1256-1264, 1998.
71. Polson J, Krazanowksi J, Fitzpatrick D: Studies on the inhibition of phosphodiesterase-catalysed cyclic AMP and cyclic GMP breakdown and relaxation of canine tracheal smooth muscle. Biochem Pharmacol 27:254-256, 1978.
72. Qureshi AI, Sung GY, Razumovsky AY, Lane K, Straw RN, Ulatowski JA: Early identification of patients at risk for symptomatic vasospasm after aneurysmal subarachnoid hemorrhage. Crit Care Med 28:984-990, 2000.
73. Roos YB, de Haan RJ, Beenen LF, Groen RJ, Albrecht KW, Vermeulen M: Complications and outcome in patients with aneurysmal subarachnoid haemorrhage: A prospective hospital based cohort study in the Netherlands. J Neurol Neurosurg Psychiatry 68:337-341, 2000.
74. Rosenwasser RH, Armonda RA, Thomas JE, Benitez RP, Gannon PM, Harrop J: Therapeutic modalities for the management of cerebral vasospasm: Timing of endovascular options. Neurosurgery 44:975-980, 1999.
75. Sawada M, Hashimoto N, Tsukahara T, Nishi S, Kaku Y, Yoshimura S: Effectiveness of intra-arterially infused Papaverine solutions of various concentrations for the treatment of cerebral vasospasm. Acta Neurochir (Wien) 139:706-711, 1997.
76. Seiler RW: Is cerebral vasospasm still a clinical problem? Acta Neurochir (Wien) 77:1-4, 2001.
77. Seiler RW, Grolimund P, Zurbruegg HR: Evaluation of the calcium-antagonist nimodipine for the prevention of vasospasm after aneurysmal subarachnoid haemorrhage. A prospective transcranial Doppler ultrasound study. Acta Neurochir (Wien) 85:7-16, 1987.
78. Seiler RW, Reulen HJ, Huber P, Grolimund P, Ebeling U, Steiger HJ: Outcome of aneurysmal subarachnoid hemorrhage in a hospital population: A prospective study including early operation, intravenous nimodipine, and transcranial Doppler ultrasound. Neurosurgery 23:598-604, 1988.
79. Smith ER, Butler WE, Barker FG 2nd: In-hospital mortality rates after ventriculoperitoneal shunt procedures in the United States, 1998 to 2000: Relation to hospital and surgeon volume of care. J Neurosurg Spine 100:90-97, 2004.
80. Smith WS, Dowd CF, Johnston SC, Ko NU, DeArmond SJ, Dillon WP, Setty D, Lawton MT, Young WL, Higashida RT, Halbach VV: Neurotoxicity of intra-arterial Papaverine preserved with chlorobutanol used for the treatment of cerebral vasospasm after aneurysmal subarachnoid hemorrhage. Stroke 35:2518-2522, 2004.
81. Terada T, Kinoshita H, Tsuura M: The effect of endovascular therapy for cerebral arterial spasm, its limitations and pitfalls. Acta Neurochir (Wien) 139:227-234, 1997.
82. Tsurushima H, Kamezaki T, Nagatomo Y, Hyodo A, Nose T: Complications associated with intraarterial administration of Papaverine for vasospasm following subarachnoid hemorrhage - Two case reports. Neurol Med Chir (Tokyo) 40:112-115, 2000.
83. Volk EE, Prayson RA, Perl J 2nd: Autopsy findings of fatal complication of posterior cerebral circulation angioplasty. Arch Pathol Lab Med 121:738-740, 1997.
84. Vorkapic P, Bevan RD, Bevan JA: Pharmacologic irreversible narrowing in chronic cerebrovasospasm in rabbits is associated with functional damage. Stroke 21:1478-1484, 1990.
85. Zubkov AY, Lewis AI, Scalzo D, Bernanke DH, Harkey HL: Morphological changes after percutaneous transluminal angioplasty. Surg Neurol 51:399-403, 1999.
86. Zubkov YN, Nikiforov BM, Shustin VA: Balloon catheter technique for dilatation of constricted cerebral arteries after aneurysmal SAH. Acta Neurochir (Wien) 70:65-79, 1984.